Difference between revisions of "Reference 46 in the bibliography for DOI: 10.3390/pathogens9020148 (Q8033)"
Jump to navigation
Jump to search
(Created a new Item: #quickstatements; #temporary_batch_1586883049685) |
(Created claim: title (P93): Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants, #quickstatements; #temporary_batch_1586889893706) |
||
| Property / title | |||
| + | Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants (English) | ||
| Property / title: Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants (English) / rank | |||
| + | Normal rank | ||
Revision as of 18:45, 14 April 2020
Publication: "Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development" in the MDPI journal Pathogens (2020); DOI: 10.3390/pathogens9020148
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Reference 46 in the bibliography for DOI: 10.3390/pathogens9020148
|
Publication: "Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development" in the MDPI journal Pathogens (2020); DOI: 10.3390/pathogens9020148
|
Statements
Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants (English)
0 references
